# KIORA PHARMACEUTICALS INC

KIORA PHARMACEUTICALS INC is a public company listed on Nasdaq as KPRX, headquartered in Encinitas, CA, United States.

## Company overview

- **Legal name:** KIORA PHARMACEUTICALS INC
- **Former names in filing history:** EYEGATE PHARMACEUTICALS INC (2006-08-09 to 2021-11-04)
- **Classification:** Public company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Encinitas, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **Ticker:** Nasdaq: KPRX
- **SEC CIK:** 0001372514

## About

KIORA PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001372514, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-25, it reported annual revenue of USD 0; net income of USD -10,835,154; total assets of USD 24,253,300 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$10.8M (USD -10,835,154)
- **Total assets:** $24.3M (USD 24,253,300)
- **Cash and equivalents:** $8.7M (USD 8,696,570)
- **Operating cash flow:** -$10.0M (USD -9,961,176)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $16.0M (USD 16,020,000)
- **Net income:** $3.6M (USD 3,594,733)
- **Total assets:** $36.5M (USD 36,484,484)
- **Cash and equivalents:** $3.8M (USD 3,792,322)
- **Operating cash flow:** $8.6M (USD 8,559,115)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2023 (period ended 2023-12-31)

- **Net income:** -$12.5M (USD -12,513,896)
- **Total assets:** $13.7M (USD 13,711,870)
- **Cash and equivalents:** $2.5M (USD 2,454,684)
- **Operating cash flow:** -$9.6M (USD -9,556,951)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$13.6M (USD -13,583,610)
- **Total assets:** $18.7M (USD 18,678,259)
- **Cash and equivalents:** $6.0M (USD 5,964,556)
- **Operating cash flow:** -$10.4M (USD -10,428,133)

## Recent SEC filings

- Form 8-K — filed 2026-09-08 — period 2026-09-08 — 8-K
- Form 8-K — filed 2026-08-19 — period 2026-08-19 — 8-K
- Form 8-K — filed 2026-08-07 — period 2026-08-07 — 8-K
- Form 10-Q — filed 2026-08-07 — period 2026-06-30 — 10-Q
- Form 8-K — filed 2026-06-18 — period 2026-06-18 — 8-K
- Form 8-K — filed 2026-06-11 — period 2026-06-10 — 8-K
- Form 8-K — filed 2026-05-08 — period 2026-05-08 — 8-K
- Form 10-Q — filed 2026-05-08 — period 2026-03-31 — 10-Q
- Form DEF 14A — filed 2026-04-30 — period 2026-04-16 — DEF 14A
- Form 8-K — filed 2026-04-07 — period 2026-04-03 — 8-K
- Form 8-K — filed 2026-04-02 — period 2026-04-01 — 8-K
- Form 8-K — filed 2026-03-25 — period 2026-03-25 — 8-K

---

Updated: 2026-10-23T06:09:42Z

Canonical page: https://altss.com/profile/kiora-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology